Cargando…

Carcinogenicity of fibrous glaucophane: How should we fill the data gaps?

• The modeled glaucophane mesothelioma potency is 0.0085 % vs. 0.5 % for riebeckite. • Lung cancer potency of glaucophane is 0.36 % vs. 4.82 % for Australian crocidolite. • The fibrosity index of glaucophane (0.77) is typical for non-asbestiform amphiboles.

Detalles Bibliográficos
Autores principales: Wylie, Ann G., Korchevskiy, Andrey A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320626/
https://www.ncbi.nlm.nih.gov/pubmed/34345861
http://dx.doi.org/10.1016/j.crtox.2021.05.004
_version_ 1783730680816992256
author Wylie, Ann G.
Korchevskiy, Andrey A.
author_facet Wylie, Ann G.
Korchevskiy, Andrey A.
author_sort Wylie, Ann G.
collection PubMed
description • The modeled glaucophane mesothelioma potency is 0.0085 % vs. 0.5 % for riebeckite. • Lung cancer potency of glaucophane is 0.36 % vs. 4.82 % for Australian crocidolite. • The fibrosity index of glaucophane (0.77) is typical for non-asbestiform amphiboles.
format Online
Article
Text
id pubmed-8320626
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83206262021-08-02 Carcinogenicity of fibrous glaucophane: How should we fill the data gaps? Wylie, Ann G. Korchevskiy, Andrey A. Curr Res Toxicol Article • The modeled glaucophane mesothelioma potency is 0.0085 % vs. 0.5 % for riebeckite. • Lung cancer potency of glaucophane is 0.36 % vs. 4.82 % for Australian crocidolite. • The fibrosity index of glaucophane (0.77) is typical for non-asbestiform amphiboles. Elsevier 2021-05-18 /pmc/articles/PMC8320626/ /pubmed/34345861 http://dx.doi.org/10.1016/j.crtox.2021.05.004 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Wylie, Ann G.
Korchevskiy, Andrey A.
Carcinogenicity of fibrous glaucophane: How should we fill the data gaps?
title Carcinogenicity of fibrous glaucophane: How should we fill the data gaps?
title_full Carcinogenicity of fibrous glaucophane: How should we fill the data gaps?
title_fullStr Carcinogenicity of fibrous glaucophane: How should we fill the data gaps?
title_full_unstemmed Carcinogenicity of fibrous glaucophane: How should we fill the data gaps?
title_short Carcinogenicity of fibrous glaucophane: How should we fill the data gaps?
title_sort carcinogenicity of fibrous glaucophane: how should we fill the data gaps?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320626/
https://www.ncbi.nlm.nih.gov/pubmed/34345861
http://dx.doi.org/10.1016/j.crtox.2021.05.004
work_keys_str_mv AT wylieanng carcinogenicityoffibrousglaucophanehowshouldwefillthedatagaps
AT korchevskiyandreya carcinogenicityoffibrousglaucophanehowshouldwefillthedatagaps